Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Adrenal Gland Diseases

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Adrenal Gland Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Debatin, JF; Huch Böni, RA; Krestin, GP1

Reviews

1 review(s) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Adrenal Gland Diseases

ArticleYear
Contrast-enhanced MR imaging of the kidneys and adrenal glands.
    Magnetic resonance imaging clinics of North America, 1996, Volume: 4, Issue:1

    Topics: Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Glands; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Kidney; Kidney Diseases; Kidney Neoplasms; Kidney Transplantation; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid

1996